The largest database of trusted experimental protocols

Alpha minimal essential media alpha mem

Manufactured by Thermo Fisher Scientific
Sourced in United States

Alpha-Minimal Essential Media (Alpha-MEM) is a cell culture medium formulated to support the growth and maintenance of a variety of cell types. It provides a balanced mixture of amino acids, vitamins, inorganic salts, and other components essential for cell metabolism and proliferation.

Automatically generated - may contain errors

2 protocols using alpha minimal essential media alpha mem

1

Vascular Differentiation of Dental Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
DPSC (Lonza, Walkersville, MD, USA) and SHED (kindly provided by Songtao Shi) were cultured in Alpha-Minimal Essential Media (Alpha-MEM; Invitrogen, Carlsbad, California) supplemented with 20% Fetal Bovine Serum (FBS; Thermo Fisher Scientific, Waltham, MA, USA), 1% Antimycotic and Antibiotic Solution (Gibco, Grand Island, NY, USA) at 37°C and 5% CO₂. Primary Human Dermal Microvascular Endothelial Cells (HDMEC; Lonza, Walkersville, MD, USA) were cultured in Endothelial Cell Growth Medium-2 (EGM2-MV; Lonza). To induce vasculogenic differentiation, SHED or DPSC were exposed to EGM2-MV supplemented with 50 ng/mL rhVEGF165 (R&D Systems, Minneapolis, MN, USA). In selected experiments, cells were exposed to 0 or 25 ug/mL anti-VEGF antibody, i.e. bevacizumab (Genentech, San Francisco, CA, USA).
+ Open protocol
+ Expand
2

Vascular Differentiation of Dental Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
DPSC (Lonza, Walkersville, MD, USA) and SHED (kindly provided by Songtao Shi) were cultured in Alpha-Minimal Essential Media (Alpha-MEM; Invitrogen, Carlsbad, California) supplemented with 20% Fetal Bovine Serum (FBS; Thermo Fisher Scientific, Waltham, MA, USA), 1% Antimycotic and Antibiotic Solution (Gibco, Grand Island, NY, USA) at 37°C and 5% CO₂. Primary Human Dermal Microvascular Endothelial Cells (HDMEC; Lonza, Walkersville, MD, USA) were cultured in Endothelial Cell Growth Medium-2 (EGM2-MV; Lonza). To induce vasculogenic differentiation, SHED or DPSC were exposed to EGM2-MV supplemented with 50 ng/mL rhVEGF165 (R&D Systems, Minneapolis, MN, USA). In selected experiments, cells were exposed to 0 or 25 ug/mL anti-VEGF antibody, i.e. bevacizumab (Genentech, San Francisco, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!